Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: QYResearch | PRODUCT CODE: 1127503

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1127503

Global Predictive Presymptomatic Testing Market Insights, Forecast to 2028

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

Description

Table of Contents

List of Tables

This research report focuses on the Predictive Presymptomatic Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Molecular Testing
    • 1.2.3 Cytogenic Testing
    • 1.2.4 Biochemical Testing
  • 1.3 Market by Application
    • 1.3.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Breast and Ovarian Cancer
    • 1.3.3 Colorectal Cancer
    • 1.3.4 Alzheimer's Disease
    • 1.3.5 Multiple Endocrine Neoplasia Type 2
    • 1.3.6 Haemochromatosis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Predictive Presymptomatic Testing Market Perspective (2017-2028)
  • 2.2 Predictive Presymptomatic Testing Growth Trends by Region
    • 2.2.1 Predictive Presymptomatic Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Predictive Presymptomatic Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 Predictive Presymptomatic Testing Market Dynamics
    • 2.3.1 Predictive Presymptomatic Testing Industry Trends
    • 2.3.2 Predictive Presymptomatic Testing Market Drivers
    • 2.3.3 Predictive Presymptomatic Testing Market Challenges
    • 2.3.4 Predictive Presymptomatic Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Predictive Presymptomatic Testing Players by Revenue
    • 3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2017-2022)
    • 3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Predictive Presymptomatic Testing Revenue
  • 3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio
    • 3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2021
  • 3.5 Predictive Presymptomatic Testing Key Players Head office and Area Served
  • 3.6 Key Players Predictive Presymptomatic Testing Product Solution and Service
  • 3.7 Date of Enter into Predictive Presymptomatic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Predictive Presymptomatic Testing Breakdown Data by Type

  • 4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2023-2028)

5 Predictive Presymptomatic Testing Breakdown Data by Application

  • 5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Predictive Presymptomatic Testing Market Size (2017-2028)
  • 6.2 North America Predictive Presymptomatic Testing Market Size by Type
    • 6.2.1 North America Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 6.2.2 North America Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 6.2.3 North America Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 6.3 North America Predictive Presymptomatic Testing Market Size by Application
    • 6.3.1 North America Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 6.3.2 North America Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 6.3.3 North America Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 6.4 North America Predictive Presymptomatic Testing Market Size by Country
    • 6.4.1 North America Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 6.4.2 North America Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Predictive Presymptomatic Testing Market Size (2017-2028)
  • 7.2 Europe Predictive Presymptomatic Testing Market Size by Type
    • 7.2.1 Europe Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 7.3 Europe Predictive Presymptomatic Testing Market Size by Application
    • 7.3.1 Europe Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 7.4 Europe Predictive Presymptomatic Testing Market Size by Country
    • 7.4.1 Europe Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type
    • 8.2.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application
    • 8.3.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region
    • 8.4.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Predictive Presymptomatic Testing Market Size (2017-2028)
  • 9.2 Latin America Predictive Presymptomatic Testing Market Size by Type
    • 9.2.1 Latin America Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 9.3 Latin America Predictive Presymptomatic Testing Market Size by Application
    • 9.3.1 Latin America Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 9.4 Latin America Predictive Presymptomatic Testing Market Size by Country
    • 9.4.1 Latin America Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type
    • 10.2.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application
    • 10.3.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country
    • 10.4.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 23andMe, Inc.
    • 11.1.1 23andMe, Inc. Company Details
    • 11.1.2 23andMe, Inc. Business Overview
    • 11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction
    • 11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.1.5 23andMe, Inc. Recent Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction
    • 11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.2.5 Abbott Laboratories Recent Developments
  • 11.3 Bayer HealthCare AG
    • 11.3.1 Bayer HealthCare AG Company Details
    • 11.3.2 Bayer HealthCare AG Business Overview
    • 11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction
    • 11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.3.5 Bayer HealthCare AG Recent Developments
  • 11.4 Biocartis SA
    • 11.4.1 Biocartis SA Company Details
    • 11.4.2 Biocartis SA Business Overview
    • 11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction
    • 11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.4.5 Biocartis SA Recent Developments
  • 11.5 BioHelix Corporation
    • 11.5.1 BioHelix Corporation Company Details
    • 11.5.2 BioHelix Corporation Business Overview
    • 11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction
    • 11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.5.5 BioHelix Corporation Recent Developments
  • 11.6 bioMerieux S.A.
    • 11.6.1 bioMerieux S.A. Company Details
    • 11.6.2 bioMerieux S.A. Business Overview
    • 11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction
    • 11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.6.5 bioMerieux S.A. Recent Developments
  • 11.7 Celera Corporation (Quest Diagnostics)
    • 11.7.1 Celera Corporation (Quest Diagnostics) Company Details
    • 11.7.2 Celera Corporation (Quest Diagnostics) Business Overview
    • 11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction
    • 11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.7.5 Celera Corporation (Quest Diagnostics) Recent Developments
  • 11.8 Cepheid (Danaher)
    • 11.8.1 Cepheid (Danaher) Company Details
    • 11.8.2 Cepheid (Danaher) Business Overview
    • 11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction
    • 11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.8.5 Cepheid (Danaher) Recent Developments
  • 11.9 Daan Diagnostics Ltd.
    • 11.9.1 Daan Diagnostics Ltd. Company Details
    • 11.9.2 Daan Diagnostics Ltd. Business Overview
    • 11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction
    • 11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.9.5 Daan Diagnostics Ltd. Recent Developments
  • 11.10 EKF Diagnostics Holdings plc
    • 11.10.1 EKF Diagnostics Holdings plc Company Details
    • 11.10.2 EKF Diagnostics Holdings plc Business Overview
    • 11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction
    • 11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.10.5 EKF Diagnostics Holdings plc Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
Show more

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Molecular Testing
    • 1.2.3 Cytogenic Testing
    • 1.2.4 Biochemical Testing
  • 1.3 Market by Application
    • 1.3.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Breast and Ovarian Cancer
    • 1.3.3 Colorectal Cancer
    • 1.3.4 Alzheimer's Disease
    • 1.3.5 Multiple Endocrine Neoplasia Type 2
    • 1.3.6 Haemochromatosis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Predictive Presymptomatic Testing Market Perspective (2017-2028)
  • 2.2 Predictive Presymptomatic Testing Growth Trends by Region
    • 2.2.1 Predictive Presymptomatic Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Predictive Presymptomatic Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 Predictive Presymptomatic Testing Market Dynamics
    • 2.3.1 Predictive Presymptomatic Testing Industry Trends
    • 2.3.2 Predictive Presymptomatic Testing Market Drivers
    • 2.3.3 Predictive Presymptomatic Testing Market Challenges
    • 2.3.4 Predictive Presymptomatic Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Predictive Presymptomatic Testing Players by Revenue
    • 3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2017-2022)
    • 3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Predictive Presymptomatic Testing Revenue
  • 3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio
    • 3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2021
  • 3.5 Predictive Presymptomatic Testing Key Players Head office and Area Served
  • 3.6 Key Players Predictive Presymptomatic Testing Product Solution and Service
  • 3.7 Date of Enter into Predictive Presymptomatic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Predictive Presymptomatic Testing Breakdown Data by Type

  • 4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2023-2028)

5 Predictive Presymptomatic Testing Breakdown Data by Application

  • 5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Predictive Presymptomatic Testing Market Size (2017-2028)
  • 6.2 North America Predictive Presymptomatic Testing Market Size by Type
    • 6.2.1 North America Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 6.2.2 North America Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 6.2.3 North America Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 6.3 North America Predictive Presymptomatic Testing Market Size by Application
    • 6.3.1 North America Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 6.3.2 North America Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 6.3.3 North America Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 6.4 North America Predictive Presymptomatic Testing Market Size by Country
    • 6.4.1 North America Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 6.4.2 North America Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Predictive Presymptomatic Testing Market Size (2017-2028)
  • 7.2 Europe Predictive Presymptomatic Testing Market Size by Type
    • 7.2.1 Europe Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 7.3 Europe Predictive Presymptomatic Testing Market Size by Application
    • 7.3.1 Europe Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 7.4 Europe Predictive Presymptomatic Testing Market Size by Country
    • 7.4.1 Europe Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type
    • 8.2.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application
    • 8.3.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region
    • 8.4.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Predictive Presymptomatic Testing Market Size (2017-2028)
  • 9.2 Latin America Predictive Presymptomatic Testing Market Size by Type
    • 9.2.1 Latin America Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 9.3 Latin America Predictive Presymptomatic Testing Market Size by Application
    • 9.3.1 Latin America Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 9.4 Latin America Predictive Presymptomatic Testing Market Size by Country
    • 9.4.1 Latin America Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type
    • 10.2.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application
    • 10.3.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country
    • 10.4.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 23andMe, Inc.
    • 11.1.1 23andMe, Inc. Company Details
    • 11.1.2 23andMe, Inc. Business Overview
    • 11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction
    • 11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.1.5 23andMe, Inc. Recent Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction
    • 11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.2.5 Abbott Laboratories Recent Developments
  • 11.3 Bayer HealthCare AG
    • 11.3.1 Bayer HealthCare AG Company Details
    • 11.3.2 Bayer HealthCare AG Business Overview
    • 11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction
    • 11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.3.5 Bayer HealthCare AG Recent Developments
  • 11.4 Biocartis SA
    • 11.4.1 Biocartis SA Company Details
    • 11.4.2 Biocartis SA Business Overview
    • 11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction
    • 11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.4.5 Biocartis SA Recent Developments
  • 11.5 BioHelix Corporation
    • 11.5.1 BioHelix Corporation Company Details
    • 11.5.2 BioHelix Corporation Business Overview
    • 11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction
    • 11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.5.5 BioHelix Corporation Recent Developments
  • 11.6 bioMerieux S.A.
    • 11.6.1 bioMerieux S.A. Company Details
    • 11.6.2 bioMerieux S.A. Business Overview
    • 11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction
    • 11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.6.5 bioMerieux S.A. Recent Developments
  • 11.7 Celera Corporation (Quest Diagnostics)
    • 11.7.1 Celera Corporation (Quest Diagnostics) Company Details
    • 11.7.2 Celera Corporation (Quest Diagnostics) Business Overview
    • 11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction
    • 11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.7.5 Celera Corporation (Quest Diagnostics) Recent Developments
  • 11.8 Cepheid (Danaher)
    • 11.8.1 Cepheid (Danaher) Company Details
    • 11.8.2 Cepheid (Danaher) Business Overview
    • 11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction
    • 11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.8.5 Cepheid (Danaher) Recent Developments
  • 11.9 Daan Diagnostics Ltd.
    • 11.9.1 Daan Diagnostics Ltd. Company Details
    • 11.9.2 Daan Diagnostics Ltd. Business Overview
    • 11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction
    • 11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.9.5 Daan Diagnostics Ltd. Recent Developments
  • 11.10 EKF Diagnostics Holdings plc
    • 11.10.1 EKF Diagnostics Holdings plc Company Details
    • 11.10.2 EKF Diagnostics Holdings plc Business Overview
    • 11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction
    • 11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.10.5 EKF Diagnostics Holdings plc Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
Show more
  • Table 1. Global Predictive Presymptomatic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Molecular Testing
  • Table 3. Key Players of Cytogenic Testing
  • Table 4. Key Players of Biochemical Testing
  • Table 5. Global Predictive Presymptomatic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Predictive Presymptomatic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Predictive Presymptomatic Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Predictive Presymptomatic Testing Market Share by Region (2017-2022)
  • Table 9. Global Predictive Presymptomatic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Predictive Presymptomatic Testing Market Share by Region (2023-2028)
  • Table 11. Predictive Presymptomatic Testing Market Trends
  • Table 12. Predictive Presymptomatic Testing Market Drivers
  • Table 13. Predictive Presymptomatic Testing Market Challenges
  • Table 14. Predictive Presymptomatic Testing Market Restraints
  • Table 15. Global Predictive Presymptomatic Testing Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Predictive Presymptomatic Testing Revenue Share by Players (2017-2022)
  • Table 17. Global Top Predictive Presymptomatic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2021)
  • Table 18. Ranking of Global Top Predictive Presymptomatic Testing Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Predictive Presymptomatic Testing Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Predictive Presymptomatic Testing Product Solution and Service
  • Table 22. Date of Enter into Predictive Presymptomatic Testing Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2017-2022)
  • Table 26. Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2023-2028)
  • Table 28. Global Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Predictive Presymptomatic Testing Revenue Share by Application (2017-2022)
  • Table 30. Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Predictive Presymptomatic Testing Revenue Share by Application (2023-2028)
  • Table 32. North America Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Predictive Presymptomatic Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Predictive Presymptomatic Testing Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. 23andMe, Inc. Company Details
  • Table 63. 23andMe, Inc. Business Overview
  • Table 64. 23andMe, Inc. Predictive Presymptomatic Testing Product
  • Table 65. 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 66. 23andMe, Inc. Recent Developments
  • Table 67. Abbott Laboratories Company Details
  • Table 68. Abbott Laboratories Business Overview
  • Table 69. Abbott Laboratories Predictive Presymptomatic Testing Product
  • Table 70. Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 71. Abbott Laboratories Recent Developments
  • Table 72. Bayer HealthCare AG Company Details
  • Table 73. Bayer HealthCare AG Business Overview
  • Table 74. Bayer HealthCare AG Predictive Presymptomatic Testing Product
  • Table 75. Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 76. Bayer HealthCare AG Recent Developments
  • Table 77. Biocartis SA Company Details
  • Table 78. Biocartis SA Business Overview
  • Table 79. Biocartis SA Predictive Presymptomatic Testing Product
  • Table 80. Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 81. Biocartis SA Recent Developments
  • Table 82. BioHelix Corporation Company Details
  • Table 83. BioHelix Corporation Business Overview
  • Table 84. BioHelix Corporation Predictive Presymptomatic Testing Product
  • Table 85. BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 86. BioHelix Corporation Recent Developments
  • Table 87. bioMerieux S.A. Company Details
  • Table 88. bioMerieux S.A. Business Overview
  • Table 89. bioMerieux S.A. Predictive Presymptomatic Testing Product
  • Table 90. bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 91. bioMerieux S.A. Recent Developments
  • Table 92. Celera Corporation (Quest Diagnostics) Company Details
  • Table 93. Celera Corporation (Quest Diagnostics) Business Overview
  • Table 94. Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Product
  • Table 95. Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 96. Celera Corporation (Quest Diagnostics) Recent Developments
  • Table 97. Cepheid (Danaher) Company Details
  • Table 98. Cepheid (Danaher) Business Overview
  • Table 99. Cepheid (Danaher) Predictive Presymptomatic Testing Product
  • Table 100. Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 101. Cepheid (Danaher) Recent Developments
  • Table 102. Daan Diagnostics Ltd. Company Details
  • Table 103. Daan Diagnostics Ltd. Business Overview
  • Table 104. Daan Diagnostics Ltd. Predictive Presymptomatic Testing Product
  • Table 105. Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 106. Daan Diagnostics Ltd. Recent Developments
  • Table 107. EKF Diagnostics Holdings plc Company Details
  • Table 108. EKF Diagnostics Holdings plc Business Overview
  • Table 109. EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Product
  • Table 110. EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 111. EKF Diagnostics Holdings plc Recent Developments
  • Table 112. Research Programs/Design for This Report
  • Table 113. Key Data Information from Secondary Sources
  • Table 114. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Predictive Presymptomatic Testing Market Share by Type: 2021 VS 2028
  • Figure 2. Molecular Testing Features
  • Figure 3. Cytogenic Testing Features
  • Figure 4. Biochemical Testing Features
  • Figure 5. Global Predictive Presymptomatic Testing Market Share by Application: 2021 VS 2028
  • Figure 6. Breast and Ovarian Cancer Case Studies
  • Figure 7. Colorectal Cancer Case Studies
  • Figure 8. Alzheimer's Disease Case Studies
  • Figure 9. Multiple Endocrine Neoplasia Type 2 Case Studies
  • Figure 10. Haemochromatosis Case Studies
  • Figure 11. Predictive Presymptomatic Testing Report Years Considered
  • Figure 12. Global Predictive Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global Predictive Presymptomatic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Predictive Presymptomatic Testing Market Share by Region: 2021 VS 2028
  • Figure 15. Global Predictive Presymptomatic Testing Market Share by Players in 2021
  • Figure 16. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by Predictive Presymptomatic Testing Revenue in 2021
  • Figure 18. North America Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 20. North America Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 21. North America Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 22. United States Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 28. Germany Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific Predictive Presymptomatic Testing Market Size Share by Region (2017-2028)
  • Figure 38. China Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 44. Latin America Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 48. Mexico Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 54. Turkey Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. 23andMe, Inc. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 58. Abbott Laboratories Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 59. Bayer HealthCare AG Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 60. Biocartis SA Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 61. BioHelix Corporation Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 62. bioMerieux S.A. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 63. Celera Corporation (Quest Diagnostics) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 64. Cepheid (Danaher) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 65. Daan Diagnostics Ltd. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 66. EKF Diagnostics Holdings plc Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!